期刊
ALLERGY
卷 76, 期 11, 页码 3408-3421出版社
WILEY
DOI: 10.1111/all.15058
关键词
atopic dermatitis; biomarkers; personalized medicine; therapy
Atopic eczema is an inflammatory skin disease influenced by genetic, immunological, and environmental factors. It is characterized by skin barrier disruption, abnormal immune response, and the impact of external factors. Prevention and appropriate treatment are crucial, and while new therapeutic options have emerged, individualized precision medicine approaches are still necessary.
Atopic eczema (AE) is an inflammatory skin disease with involvement of genetic, immunological and environmental factors. One hallmark of AE is a skin barrier disruption on multiple, highly interconnected levels: filaggrin mutations, increased skin pH and a microbiome dysbiosis towards Staphylococcus aureus overgrowth are observed in addition to an abnormal type 2 immune response. Extrinsic factors seem to play a major role in the development of AE. As AE is a first step in the atopic march, its prevention and appropriate treatment are essential. Although standard therapy remains topical treatment, powerful systemic treatment options emerged in the last years. However, thorough endotyping of the individual patients is still required for ideal precision medicine approaches in future. Therefore, novel microbial and immunological biomarkers were described recently for the prediction of disease development and treatment response. This review summarizes the current state of the art in AE research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据